^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
04/28/2021
Excerpt:
Soft Tissue Sarcoma: Preferred Regimens...AIM (doxorubicin, ifosfamide, mesna)